0001209191-18-019742.txt : 20180314
0001209191-18-019742.hdr.sgml : 20180314
20180314211137
ACCESSION NUMBER: 0001209191-18-019742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180312
FILED AS OF DATE: 20180314
DATE AS OF CHANGE: 20180314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tucker Sean
CENTRAL INDEX KEY: 0001652204
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35285
FILM NUMBER: 18690872
MAIL ADDRESS:
STREET 1: 385 OYSTER POINT BLVD., SUITE 9A
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxart, Inc.
CENTRAL INDEX KEY: 0000072444
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 591212264
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 290 UTAH AVE., SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 550-3500
MAIL ADDRESS:
STREET 1: 290 UTAH AVE., SUITE 200
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Aviragen Therapeutics, Inc.
DATE OF NAME CHANGE: 20160413
FORMER COMPANY:
FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20121113
FORMER COMPANY:
FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS
DATE OF NAME CHANGE: 20100719
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-12
0
0000072444
Vaxart, Inc.
VXRT
0001652204
Tucker Sean
395 OYSTER POINT BLVD, SUITE 405
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
Common Stock
2018-03-12
4
M
0
2013
6.49
A
47653
D
Common Stock
9060
I
By spouse
Common Stock
25388
I
By joint trust with Frances Chang and Sean Tucker
Stock Option (right to buy)
6.49
2018-03-12
4
M
0
2013
0.00
D
2018-03-13
Common Stock
2013
0
D
The option is fully vested.
/s/ John T. McKenna, Attorney-in-Fact
2018-03-14